<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang T</submitter><funding>山东省科学技术厅 | Natural Science Foundation of Shandong Province</funding><funding>| Natural Science Foundation of Shandong Province ()</funding><funding>MOST | National Natural Science Foundation of China (NSFC)</funding><funding>MOST | National Natural Science Foundation of China</funding><pagination>e0015924</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11019850</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>98(4)</volume><pubmed_abstract>Equine herpesvirus type 8 (EHV-8) causes abortion and respiratory disease in horses and donkeys, leading to serious economic losses in the global equine industry. Currently, there is no effective vaccine or drug against EHV-8 infection, underscoring the need for a novel antiviral drug to prevent EHV-8-induced latent infection and decrease the pathogenicity of this virus. The present study demonstrated that hyperoside can exert antiviral effects against EHV-8 infection in RK-13 (rabbit kidney cells), MDBK (Madin-Darby bovine kidney), and NBL-6 cells (E. Derm cells). Mechanistic investigations revealed that hyperoside induces heme oxygenase-1 expression by activating the c-Jun N-terminal kinase/nuclear factor erythroid-2-related factor 2/Kelch-like ECH-associated protein 1 axis, alleviating </pubmed_abstract><journal>Journal of virology</journal><pubmed_title>Hyperoside inhibits EHV-8 infection via alleviating oxidative stress and IFN production through activating JNK/Keap1/Nrf2/HO-1 signaling pathways.</pubmed_title><pmcid>PMC11019850</pmcid><funding_grant_id>ZR2020QC017</funding_grant_id><funding_grant_id>ZR2020QC016</funding_grant_id><funding_grant_id>32002248</funding_grant_id><pubmed_authors>Ren H</pubmed_authors><pubmed_authors>Ding X</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Li S</pubmed_authors><pubmed_authors>Sun Q</pubmed_authors><pubmed_authors>Wang C</pubmed_authors><pubmed_authors>Wang T</pubmed_authors><pubmed_authors>Hu L</pubmed_authors><pubmed_authors>Li R</pubmed_authors><pubmed_authors>Li L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Hyperoside inhibits EHV-8 infection via alleviating oxidative stress and IFN production through activating JNK/Keap1/Nrf2/HO-1 signaling pathways.</name><description>Equine herpesvirus type 8 (EHV-8) causes abortion and respiratory disease in horses and donkeys, leading to serious economic losses in the global equine industry. Currently, there is no effective vaccine or drug against EHV-8 infection, underscoring the need for a novel antiviral drug to prevent EHV-8-induced latent infection and decrease the pathogenicity of this virus. The present study demonstrated that hyperoside can exert antiviral effects against EHV-8 infection in RK-13 (rabbit kidney cells), MDBK (Madin-Darby bovine kidney), and NBL-6 cells (E. Derm cells). Mechanistic investigations revealed that hyperoside induces heme oxygenase-1 expression by activating the c-Jun N-terminal kinase/nuclear factor erythroid-2-related factor 2/Kelch-like ECH-associated protein 1 axis, alleviating </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Apr</publication><modification>2026-06-02T11:34:00.284Z</modification><creation>2025-04-06T00:48:12.09Z</creation></dates><accession>S-EPMC11019850</accession><cross_references><pubmed>38499512</pubmed><doi>10.1128/jvi.00159-24</doi></cross_references></HashMap>